These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29652212)

  • 1. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.
    Kindts I; Defraene G; Laenen A; Petillion S; Van Limbergen E; Depuydt T; Weltens C
    Acta Oncol; 2018 Jul; 57(7):916-923. PubMed ID: 29652212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.
    Kindts I; Defraene G; Petillion S; Janssen H; Van Limbergen E; Depuydt T; Weltens C
    Acta Oncol; 2019 Apr; 58(4):448-455. PubMed ID: 30638097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
    Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
    Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort Study.
    Hennigs A; Biehl H; Rauch G; Golatta M; Tabatabai P; Domschke C; Schott S; Wallwiener M; Schütz F; Sohn C; Heil J
    Ann Surg Oncol; 2016 May; 23(5):1744-51. PubMed ID: 26545376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials.
    Mukesh MB; Harris E; Collette S; Coles CE; Bartelink H; Wilkinson J; Evans PM; Graham P; Haviland J; Poortmans P; Yarnold J; Jena R
    Radiother Oncol; 2013 Aug; 108(2):293-8. PubMed ID: 23953408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
    Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
    Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cosmetic results after breast conserving carcinoma treatment in patients with intramammarian seromas].
    Schultze J; Lössl K; Kimmig B
    Rontgenpraxis; 2008; 56(5):169-80. PubMed ID: 19294874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complication probability model for subcutaneous fibrosis based on published data of partial and whole breast irradiation.
    Avanzo M; Stancanello J; Trovò M; Jena R; Roncadin M; Trovò MG; Capra E
    Phys Med; 2012 Oct; 28(4):296-306. PubMed ID: 22119271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?
    Cella L; Palma G; Deasy JO; Oh JH; Liuzzi R; D'Avino V; Conson M; Pugliese N; Picardi M; Salvatore M; Pacelli R
    PLoS One; 2014; 9(10):e111753. PubMed ID: 25360627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
    Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
    Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome.
    Kindts I; Laenen A; Christiaens M; Janssen H; Van Limbergen E; Weltens C
    Strahlenther Onkol; 2019 Jan; 195(1):21-31. PubMed ID: 30140943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
    Moore KL; Schmidt R; Moiseenko V; Olsen LA; Tan J; Xiao Y; Galvin J; Pugh S; Seider MJ; Dicker AP; Bosch W; Michalski J; Mutic S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):228-35. PubMed ID: 25847605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.
    Zhou ZR; Han Q; Liang SX; He XD; Cao NY; Zi YJ
    Oncotarget; 2017 May; 8(20):33855-33863. PubMed ID: 27806340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
    Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA; Li XA
    Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
    Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.